Subscribe to Search results

Approval was granted for the use of a screening test for AIDS antibodies in the NBTS.

Published on:

Professor Arthur Bloom wrote to the DHSS: more testing staff were needed as was funding to develop British HTLV-3 antibody test kits.

Published on:

The EAGA met for the first time and discussed work being carried out to develop a screening test.

Published on:

The DHSS told the chair of the regional transfusion directors in England that it was in the interests of the blood services to delay testing until tests had been properly evaluated.

Published on:

Several countries had started screening blood donations; the UK was still evaluating tests and considering how best to implement blood donation screening.

Published on:

John Patten questioned the CMO "on the overall position" regarding testing, prompting the DCMO to demand a critical path analysis from the PHLS director.

Published on:

Professor Bloom wrote to the DCMO stating that one or more of the FDA-approved tests should be introduced immediately.

Published on:

Kenneth Clarke announced that an AIDS blood test would be introduced within the next few months.

Published on:

The PHLS recommended three tests to the EAGA as most suitable for use in diagnostic laboratories, two of which were particularly suitable for use in blood transfusion centres.

Published on:

The NBTS started routine screening of all blood donations for antibodies to HTLV-3.

Published on:

BPL was extended in a "make and mend" operation.

Published on:

The SHHD drew up plans to build PFC and made a formal agreement with the Ministry of Health to fractionate plasma from four northern English regions.

Published on:

Dr Biggs wrote to the CMO calling for the new buildings at Elstree and in Edinburgh to be accelerated in order to enable greater domestic production of concentrates.

Published on:

Dr Maycock wrote to the DHSS urging them to "have constantly in mind the need to develop our own sources in the UK transfusion services".

Published on:

The Expert Group on the Treatment of Haemophilia met for the first time.

Published on:

The Expert Group on the Treatment of Haemophilia decided the initial aim would be to provide anti-haemophilic globulin concentrate from 250,000 donations.

Published on:

An MRC report noted that to meet the requirements of Factor 8 the total material needed was likely to be 547,540-750,000 blood donations per annum.

Published on:

The DHSS wrote to regional administrators that the immediate need for AHG concentrate, the cost of commercial alternatives, and the potential threat to the voluntary donor system meant achieving self-sufficiency was "of the greatest importance".

Published on:

Dr Owen announced the Government's committment to self-sufficiency and the allocation of special finance in furtherance of this goal.

Published on:

Dr Bidwell calculated that between 970,920 and 1,213,650 donations would need to be devoted to plasma supply to produce the required amount of Factor 8.

Published on: